Correlation Between Kilitch Drugs and Consolidated Construction

Can any of the company-specific risk be diversified away by investing in both Kilitch Drugs and Consolidated Construction at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kilitch Drugs and Consolidated Construction into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kilitch Drugs Limited and Consolidated Construction Consortium, you can compare the effects of market volatilities on Kilitch Drugs and Consolidated Construction and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kilitch Drugs with a short position of Consolidated Construction. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kilitch Drugs and Consolidated Construction.

Diversification Opportunities for Kilitch Drugs and Consolidated Construction

0.19

Correlation Coefficient

Kilitch Drugs  Consolidated Construction

Average diversification

The 3 months correlation between Kilitch and Consolidated is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Kilitch Drugs Limited and Consolidated Construction Cons in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Consolidated Construction and Kilitch Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kilitch Drugs Limited are associated (or correlated) with Consolidated Construction. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Consolidated Construction has no effect on the direction of Kilitch Drugs i.e., Kilitch Drugs and Consolidated Construction go up and down completely randomly.

Pair Corralation between Kilitch Drugs and Consolidated Construction

Assuming the 90 days trading horizon Kilitch Drugs Limited is expected to under-perform the Consolidated Construction. But the stock apears to be less risky and, when comparing its historical volatility, Kilitch Drugs Limited is 1.37 times less risky than Consolidated Construction. The stock trades about -0.02 of its potential returns per unit of risk. The Consolidated Construction Consortium is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  1,201  in Consolidated Construction Consortium on September 4, 2024 and sell it today you would earn a total of  699.00  from holding Consolidated Construction Consortium or generate 58.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Kilitch Drugs Limited  vs.  Consolidated Construction Cons

Kilitch Drugs Limited

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kilitch Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Kilitch Drugs is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Consolidated Construction

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Consolidated Construction Consortium are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Consolidated Construction unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Kilitch Drugs and Consolidated Construction

The main advantage of trading using opposite Kilitch Drugs and Consolidated Construction positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kilitch Drugs position performs unexpectedly, Consolidated Construction can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Consolidated Construction will offset losses from the drop in Consolidated Construction's long position.

The idea behind Kilitch Drugs Limited and Consolidated Construction Consortium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.